Prawo i regulacje · 28/07/2005

DEA Places Pregabalin in Schedule V, Implying Stricter Controls on the Medication

The Drug Enforcement Administration (DEA) has issued a final rule to classify pregabalin, a medication used to treat epilepsy and chronic pain, as a Schedule V controlled substance, subjecting it to stricter regulations and penalties